olprinone has been researched along with Intraventricular Septal Defects in 2 studies
olprinone: RN refers to HCl; structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty-six infants with pulmonary hypertension undergoing ventricular septum defect repair were retrospectively allocated to milrinone group (n= 13)and olprinone group(n=13)." | 3.79 | [Comparison of the effects of phosphodiesterase III inhibitors, milrinone and olprinone, in infant corrective cardiac surgery]. ( Izumi, K; Jimi, N; Mizuno, K; Sakimura, S; Sumiyoshi, R; Yoshino, J, 2013) |
| "Olprinone was administered as a bolus, 20 microg/kg body weight, and hemodynamic data were obtained before and after the administration." | 1.31 | Hemodynamic effects of phosphodiesterase III inhibitor in patients with a large ventricular left-to-right shunt. ( Kobayashi, T; Momoi, N; Sato, K; Sato, M; Sato, T; Suzuki, H, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakimura, S | 1 |
| Yoshino, J | 1 |
| Izumi, K | 1 |
| Jimi, N | 1 |
| Sumiyoshi, R | 1 |
| Mizuno, K | 1 |
| Momoi, N | 1 |
| Sato, M | 1 |
| Sato, K | 1 |
| Sato, T | 1 |
| Kobayashi, T | 1 |
| Suzuki, H | 2 |
2 other studies available for olprinone and Intraventricular Septal Defects
| Article | Year |
|---|---|
[Comparison of the effects of phosphodiesterase III inhibitors, milrinone and olprinone, in infant corrective cardiac surgery].
Topics: Cardiac Surgical Procedures; Female; Heart Septal Defects, Ventricular; Hemodynamics; Humans; Hypert | 2013 |
Hemodynamic effects of phosphodiesterase III inhibitor in patients with a large ventricular left-to-right shunt.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cyclic Nucleotide Phosphodiesterases, Type 3; Heart Septal Defe | 2000 |